TW468040B - A method for the assessment of particles and a system and a device for use in the method - Google Patents
A method for the assessment of particles and a system and a device for use in the method Download PDFInfo
- Publication number
- TW468040B TW468040B TW088120318A TW88120318A TW468040B TW 468040 B TW468040 B TW 468040B TW 088120318 A TW088120318 A TW 088120318A TW 88120318 A TW88120318 A TW 88120318A TW 468040 B TW468040 B TW 468040B
- Authority
- TW
- Taiwan
- Prior art keywords
- sample
- patent application
- scope
- volume
- item
- Prior art date
Links
- 239000002245 particle Substances 0.000 title claims abstract description 138
- 238000000034 method Methods 0.000 title claims abstract description 92
- 239000007788 liquid Substances 0.000 claims abstract description 128
- 238000001514 detection method Methods 0.000 claims abstract description 116
- 239000000463 material Substances 0.000 claims abstract description 55
- 238000012545 processing Methods 0.000 claims abstract description 39
- 239000012491 analyte Substances 0.000 claims abstract description 37
- 239000000523 sample Substances 0.000 claims description 467
- 238000006243 chemical reaction Methods 0.000 claims description 87
- 239000000126 substance Substances 0.000 claims description 58
- 238000011156 evaluation Methods 0.000 claims description 33
- 210000001082 somatic cell Anatomy 0.000 claims description 32
- 238000005259 measurement Methods 0.000 claims description 30
- 241000894006 Bacteria Species 0.000 claims description 25
- 230000005670 electromagnetic radiation Effects 0.000 claims description 25
- 230000000694 effects Effects 0.000 claims description 23
- 230000008859 change Effects 0.000 claims description 21
- 239000007787 solid Substances 0.000 claims description 20
- 239000000975 dye Substances 0.000 claims description 14
- 238000002156 mixing Methods 0.000 claims description 13
- 238000005424 photoluminescence Methods 0.000 claims description 13
- XJMOSONTPMZWPB-UHFFFAOYSA-M propidium iodide Chemical compound [I-].[I-].C12=CC(N)=CC=C2C2=CC=C(N)C=C2[N+](CCC[N+](C)(CC)CC)=C1C1=CC=CC=C1 XJMOSONTPMZWPB-UHFFFAOYSA-M 0.000 claims description 13
- 239000000980 acid dye Substances 0.000 claims description 11
- 238000001914 filtration Methods 0.000 claims description 11
- 102000039446 nucleic acids Human genes 0.000 claims description 10
- 108020004707 nucleic acids Proteins 0.000 claims description 10
- 150000007523 nucleic acids Chemical class 0.000 claims description 10
- 108090000623 proteins and genes Proteins 0.000 claims description 9
- 102000004169 proteins and genes Human genes 0.000 claims description 9
- 238000012790 confirmation Methods 0.000 claims description 8
- 238000004090 dissolution Methods 0.000 claims description 8
- 230000005291 magnetic effect Effects 0.000 claims description 8
- 238000001069 Raman spectroscopy Methods 0.000 claims description 7
- 238000013461 design Methods 0.000 claims description 7
- 230000001965 increasing effect Effects 0.000 claims description 5
- 230000003993 interaction Effects 0.000 claims description 5
- 230000008569 process Effects 0.000 claims description 5
- 230000001105 regulatory effect Effects 0.000 claims description 5
- 230000003313 weakening effect Effects 0.000 claims description 5
- CURLTUGMZLYLDI-UHFFFAOYSA-N Carbon dioxide Chemical compound O=C=O CURLTUGMZLYLDI-UHFFFAOYSA-N 0.000 claims description 4
- JUJWROOIHBZHMG-UHFFFAOYSA-N Pyridine Chemical compound C1=CC=NC=C1 JUJWROOIHBZHMG-UHFFFAOYSA-N 0.000 claims description 4
- 239000010408 film Substances 0.000 claims description 4
- 150000002500 ions Chemical class 0.000 claims description 4
- 239000003068 molecular probe Substances 0.000 claims description 4
- RDOWQLZANAYVLL-UHFFFAOYSA-N phenanthridine Chemical compound C1=CC=C2C3=CC=CC=C3C=NC2=C1 RDOWQLZANAYVLL-UHFFFAOYSA-N 0.000 claims description 4
- 239000002904 solvent Substances 0.000 claims description 4
- 239000010409 thin film Substances 0.000 claims description 4
- 238000005481 NMR spectroscopy Methods 0.000 claims description 3
- XSQUKJJJFZCRTK-UHFFFAOYSA-N Urea Chemical compound NC(N)=O XSQUKJJJFZCRTK-UHFFFAOYSA-N 0.000 claims description 3
- 239000000427 antigen Substances 0.000 claims description 3
- 102000036639 antigens Human genes 0.000 claims description 3
- 108091007433 antigens Proteins 0.000 claims description 3
- 230000006837 decompression Effects 0.000 claims description 3
- XMBWDFGMSWQBCA-UHFFFAOYSA-N hydrogen iodide Chemical compound I XMBWDFGMSWQBCA-UHFFFAOYSA-N 0.000 claims description 3
- 230000005855 radiation Effects 0.000 claims description 3
- 230000009467 reduction Effects 0.000 claims description 3
- 150000003839 salts Chemical class 0.000 claims description 3
- GPRLSGONYQIRFK-MNYXATJNSA-N triton Chemical compound [3H+] GPRLSGONYQIRFK-MNYXATJNSA-N 0.000 claims description 3
- PRDFBSVERLRRMY-UHFFFAOYSA-N 2'-(4-ethoxyphenyl)-5-(4-methylpiperazin-1-yl)-2,5'-bibenzimidazole Chemical compound C1=CC(OCC)=CC=C1C1=NC2=CC=C(C=3NC4=CC(=CC=C4N=3)N3CCN(C)CC3)C=C2N1 PRDFBSVERLRRMY-UHFFFAOYSA-N 0.000 claims description 2
- DOETVZCFKJCYJV-UHFFFAOYSA-N 6-(4,5-dihydro-1h-imidazol-2-yl)-2-[4-(4,5-dihydro-1h-imidazol-2-yl)phenyl]-1h-indole Chemical compound N1CCN=C1C1=CC=C(C=2NC3=CC(=CC=C3C=2)C=2NCCN=2)C=C1 DOETVZCFKJCYJV-UHFFFAOYSA-N 0.000 claims description 2
- GUBGYTABKSRVRQ-XLOQQCSPSA-N Alpha-Lactose Chemical compound O[C@@H]1[C@@H](O)[C@@H](O)[C@@H](CO)O[C@H]1O[C@@H]1[C@@H](CO)O[C@H](O)[C@H](O)[C@H]1O GUBGYTABKSRVRQ-XLOQQCSPSA-N 0.000 claims description 2
- OYPRJOBELJOOCE-UHFFFAOYSA-N Calcium Chemical compound [Ca] OYPRJOBELJOOCE-UHFFFAOYSA-N 0.000 claims description 2
- 101100286286 Dictyostelium discoideum ipi gene Proteins 0.000 claims description 2
- WQZGKKKJIJFFOK-GASJEMHNSA-N Glucose Natural products OC[C@H]1OC(O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-GASJEMHNSA-N 0.000 claims description 2
- DGAQECJNVWCQMB-PUAWFVPOSA-M Ilexoside XXIX Chemical compound C[C@@H]1CC[C@@]2(CC[C@@]3(C(=CC[C@H]4[C@]3(CC[C@@H]5[C@@]4(CC[C@@H](C5(C)C)OS(=O)(=O)[O-])C)C)[C@@H]2[C@]1(C)O)C)C(=O)O[C@H]6[C@@H]([C@H]([C@@H]([C@H](O6)CO)O)O)O.[Na+] DGAQECJNVWCQMB-PUAWFVPOSA-M 0.000 claims description 2
- GUBGYTABKSRVRQ-QKKXKWKRSA-N Lactose Natural products OC[C@H]1O[C@@H](O[C@H]2[C@H](O)[C@@H](O)C(O)O[C@@H]2CO)[C@H](O)[C@@H](O)[C@H]1O GUBGYTABKSRVRQ-QKKXKWKRSA-N 0.000 claims description 2
- ZLMJMSJWJFRBEC-UHFFFAOYSA-N Potassium Chemical compound [K] ZLMJMSJWJFRBEC-UHFFFAOYSA-N 0.000 claims description 2
- QVGXLLKOCUKJST-UHFFFAOYSA-N atomic oxygen Chemical compound [O] QVGXLLKOCUKJST-UHFFFAOYSA-N 0.000 claims description 2
- WQZGKKKJIJFFOK-VFUOTHLCSA-N beta-D-glucose Chemical compound OC[C@H]1O[C@@H](O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-VFUOTHLCSA-N 0.000 claims description 2
- 239000011575 calcium Substances 0.000 claims description 2
- 229910052791 calcium Inorganic materials 0.000 claims description 2
- 239000004202 carbamide Substances 0.000 claims description 2
- 239000001569 carbon dioxide Substances 0.000 claims description 2
- 229910002092 carbon dioxide Inorganic materials 0.000 claims description 2
- 239000008103 glucose Substances 0.000 claims description 2
- 239000008101 lactose Substances 0.000 claims description 2
- 229910052760 oxygen Inorganic materials 0.000 claims description 2
- 239000001301 oxygen Substances 0.000 claims description 2
- NQZHNXUQNNSNAS-UHFFFAOYSA-N phenanthridin-5-ium;bromide Chemical compound [Br-].C1=CC=C2C3=CC=CC=C3C=[NH+]C2=C1 NQZHNXUQNNSNAS-UHFFFAOYSA-N 0.000 claims description 2
- INAAIJLSXJJHOZ-UHFFFAOYSA-N pibenzimol Chemical compound C1CN(C)CCN1C1=CC=C(N=C(N2)C=3C=C4NC(=NC4=CC=3)C=3C=CC(O)=CC=3)C2=C1 INAAIJLSXJJHOZ-UHFFFAOYSA-N 0.000 claims description 2
- 239000011591 potassium Substances 0.000 claims description 2
- 229910052700 potassium Inorganic materials 0.000 claims description 2
- UMJSCPRVCHMLSP-UHFFFAOYSA-N pyridine Natural products COC1=CC=CN=C1 UMJSCPRVCHMLSP-UHFFFAOYSA-N 0.000 claims description 2
- 230000004044 response Effects 0.000 claims description 2
- 239000011734 sodium Substances 0.000 claims description 2
- 229910052708 sodium Inorganic materials 0.000 claims description 2
- 238000012360 testing method Methods 0.000 claims description 2
- ANRHNWWPFJCPAZ-UHFFFAOYSA-M thionine Chemical compound [Cl-].C1=CC(N)=CC2=[S+]C3=CC(N)=CC=C3N=C21 ANRHNWWPFJCPAZ-UHFFFAOYSA-M 0.000 claims description 2
- RAXXELZNTBOGNW-UHFFFAOYSA-N imidazole Natural products C1=CNC=N1 RAXXELZNTBOGNW-UHFFFAOYSA-N 0.000 claims 3
- 239000000470 constituent Substances 0.000 claims 2
- 239000003085 diluting agent Substances 0.000 claims 2
- 238000002798 spectrophotometry method Methods 0.000 claims 2
- PCTMTFRHKVHKIS-BMFZQQSSSA-N (1s,3r,4e,6e,8e,10e,12e,14e,16e,18s,19r,20r,21s,25r,27r,30r,31r,33s,35r,37s,38r)-3-[(2r,3s,4s,5s,6r)-4-amino-3,5-dihydroxy-6-methyloxan-2-yl]oxy-19,25,27,30,31,33,35,37-octahydroxy-18,20,21-trimethyl-23-oxo-22,39-dioxabicyclo[33.3.1]nonatriaconta-4,6,8,10 Chemical compound C1C=C2C[C@@H](OS(O)(=O)=O)CC[C@]2(C)[C@@H]2[C@@H]1[C@@H]1CC[C@H]([C@H](C)CCCC(C)C)[C@@]1(C)CC2.O[C@H]1[C@@H](N)[C@H](O)[C@@H](C)O[C@H]1O[C@H]1/C=C/C=C/C=C/C=C/C=C/C=C/C=C/[C@H](C)[C@@H](O)[C@@H](C)[C@H](C)OC(=O)C[C@H](O)C[C@H](O)CC[C@@H](O)[C@H](O)C[C@H](O)C[C@](O)(C[C@H](O)[C@H]2C(O)=O)O[C@H]2C1 PCTMTFRHKVHKIS-BMFZQQSSSA-N 0.000 claims 1
- KRKNYBCHXYNGOX-UHFFFAOYSA-K Citrate Chemical compound [O-]C(=O)CC(O)(CC([O-])=O)C([O-])=O KRKNYBCHXYNGOX-UHFFFAOYSA-K 0.000 claims 1
- 229910052692 Dysprosium Inorganic materials 0.000 claims 1
- SJEYSFABYSGQBG-UHFFFAOYSA-M Patent blue Chemical compound [Na+].C1=CC(N(CC)CC)=CC=C1C(C=1C(=CC(=CC=1)S([O-])(=O)=O)S([O-])(=O)=O)=C1C=CC(=[N+](CC)CC)C=C1 SJEYSFABYSGQBG-UHFFFAOYSA-M 0.000 claims 1
- YZCKVEUIGOORGS-NJFSPNSNSA-N Tritium Chemical compound [3H] YZCKVEUIGOORGS-NJFSPNSNSA-N 0.000 claims 1
- 239000008186 active pharmaceutical agent Substances 0.000 claims 1
- 238000009530 blood pressure measurement Methods 0.000 claims 1
- 230000008602 contraction Effects 0.000 claims 1
- 238000012937 correction Methods 0.000 claims 1
- KBQHZAAAGSGFKK-UHFFFAOYSA-N dysprosium atom Chemical compound [Dy] KBQHZAAAGSGFKK-UHFFFAOYSA-N 0.000 claims 1
- 238000011835 investigation Methods 0.000 claims 1
- 238000004020 luminiscence type Methods 0.000 claims 1
- UYDLBVPAAFVANX-UHFFFAOYSA-N octylphenoxy polyethoxyethanol Chemical compound CC(C)(C)CC(C)(C)C1=CC=C(OCCOCCOCCOCCO)C=C1 UYDLBVPAAFVANX-UHFFFAOYSA-N 0.000 claims 1
- 102000040430 polynucleotide Human genes 0.000 claims 1
- 108091033319 polynucleotide Proteins 0.000 claims 1
- 238000003672 processing method Methods 0.000 claims 1
- 238000006722 reduction reaction Methods 0.000 claims 1
- 230000035939 shock Effects 0.000 claims 1
- 239000013589 supplement Substances 0.000 claims 1
- 229910052722 tritium Inorganic materials 0.000 claims 1
- 238000004458 analytical method Methods 0.000 description 44
- 238000011049 filling Methods 0.000 description 35
- 235000013336 milk Nutrition 0.000 description 28
- 239000008267 milk Substances 0.000 description 28
- 210000004080 milk Anatomy 0.000 description 28
- 239000000203 mixture Substances 0.000 description 24
- 210000004027 cell Anatomy 0.000 description 20
- 239000011324 bead Substances 0.000 description 17
- 230000002079 cooperative effect Effects 0.000 description 17
- 210000004369 blood Anatomy 0.000 description 13
- 239000008280 blood Substances 0.000 description 13
- 241000607142 Salmonella Species 0.000 description 12
- 239000003153 chemical reaction reagent Substances 0.000 description 12
- 239000004615 ingredient Substances 0.000 description 11
- 235000013365 dairy product Nutrition 0.000 description 8
- 239000007789 gas Substances 0.000 description 7
- 239000000243 solution Substances 0.000 description 7
- 238000003860 storage Methods 0.000 description 7
- 230000000704 physical effect Effects 0.000 description 6
- 230000008901 benefit Effects 0.000 description 5
- 235000013305 food Nutrition 0.000 description 5
- 230000003287 optical effect Effects 0.000 description 5
- 238000005070 sampling Methods 0.000 description 5
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 5
- QGZKDVFQNNGYKY-UHFFFAOYSA-O Ammonium Chemical compound [NH4+] QGZKDVFQNNGYKY-UHFFFAOYSA-O 0.000 description 4
- 241001465754 Metazoa Species 0.000 description 4
- 230000001580 bacterial effect Effects 0.000 description 4
- 230000000875 corresponding effect Effects 0.000 description 4
- 239000000383 hazardous chemical Substances 0.000 description 4
- 238000004519 manufacturing process Methods 0.000 description 4
- 238000007614 solvation Methods 0.000 description 4
- 210000002700 urine Anatomy 0.000 description 4
- 239000007864 aqueous solution Substances 0.000 description 3
- 238000004364 calculation method Methods 0.000 description 3
- KRKNYBCHXYNGOX-UHFFFAOYSA-N citric acid Chemical compound OC(=O)CC(O)(C(O)=O)CC(O)=O KRKNYBCHXYNGOX-UHFFFAOYSA-N 0.000 description 3
- 238000010790 dilution Methods 0.000 description 3
- 239000012895 dilution Substances 0.000 description 3
- 239000006185 dispersion Substances 0.000 description 3
- 238000005516 engineering process Methods 0.000 description 3
- 238000000855 fermentation Methods 0.000 description 3
- 230000004151 fermentation Effects 0.000 description 3
- 238000002309 gasification Methods 0.000 description 3
- 238000012423 maintenance Methods 0.000 description 3
- 230000004048 modification Effects 0.000 description 3
- 238000012986 modification Methods 0.000 description 3
- 230000005298 paramagnetic effect Effects 0.000 description 3
- 229920000642 polymer Polymers 0.000 description 3
- 230000035945 sensitivity Effects 0.000 description 3
- 230000003068 static effect Effects 0.000 description 3
- 241000283690 Bos taurus Species 0.000 description 2
- 241000283707 Capra Species 0.000 description 2
- 229920004890 Triton X-100 Polymers 0.000 description 2
- 239000013504 Triton X-100 Substances 0.000 description 2
- 230000015572 biosynthetic process Effects 0.000 description 2
- 210000000601 blood cell Anatomy 0.000 description 2
- 238000004820 blood count Methods 0.000 description 2
- 238000004140 cleaning Methods 0.000 description 2
- 230000005284 excitation Effects 0.000 description 2
- 239000007850 fluorescent dye Substances 0.000 description 2
- 239000012634 fragment Substances 0.000 description 2
- 230000006870 function Effects 0.000 description 2
- 210000000265 leukocyte Anatomy 0.000 description 2
- 239000011344 liquid material Substances 0.000 description 2
- 208000004396 mastitis Diseases 0.000 description 2
- 230000000877 morphologic effect Effects 0.000 description 2
- 239000002861 polymer material Substances 0.000 description 2
- 239000011148 porous material Substances 0.000 description 2
- 230000000717 retained effect Effects 0.000 description 2
- 238000007493 shaping process Methods 0.000 description 2
- 238000011282 treatment Methods 0.000 description 2
- 238000011144 upstream manufacturing Methods 0.000 description 2
- HYZJCKYKOHLVJF-UHFFFAOYSA-N 1H-benzimidazole Chemical compound C1=CC=C2NC=NC2=C1 HYZJCKYKOHLVJF-UHFFFAOYSA-N 0.000 description 1
- FWBHETKCLVMNFS-UHFFFAOYSA-N 4',6-Diamino-2-phenylindol Chemical compound C1=CC(C(=N)N)=CC=C1C1=CC2=CC=C(C(N)=N)C=C2N1 FWBHETKCLVMNFS-UHFFFAOYSA-N 0.000 description 1
- 244000003363 Allium ursinum Species 0.000 description 1
- KCXVZYZYPLLWCC-UHFFFAOYSA-N EDTA Chemical compound OC(=O)CN(CC(O)=O)CCN(CC(O)=O)CC(O)=O KCXVZYZYPLLWCC-UHFFFAOYSA-N 0.000 description 1
- 102000004190 Enzymes Human genes 0.000 description 1
- 108090000790 Enzymes Proteins 0.000 description 1
- 206010061218 Inflammation Diseases 0.000 description 1
- 206010028980 Neoplasm Diseases 0.000 description 1
- 241000282320 Panthera leo Species 0.000 description 1
- 241001494479 Pecora Species 0.000 description 1
- 230000002159 abnormal effect Effects 0.000 description 1
- 230000005856 abnormality Effects 0.000 description 1
- 239000002253 acid Substances 0.000 description 1
- 230000004913 activation Effects 0.000 description 1
- 239000000853 adhesive Substances 0.000 description 1
- 230000001070 adhesive effect Effects 0.000 description 1
- 239000003242 anti bacterial agent Substances 0.000 description 1
- 229940088710 antibiotic agent Drugs 0.000 description 1
- 238000004159 blood analysis Methods 0.000 description 1
- 201000011510 cancer Diseases 0.000 description 1
- 210000005056 cell body Anatomy 0.000 description 1
- 238000010276 construction Methods 0.000 description 1
- 230000001276 controlling effect Effects 0.000 description 1
- 238000001816 cooling Methods 0.000 description 1
- 230000002596 correlated effect Effects 0.000 description 1
- 230000006378 damage Effects 0.000 description 1
- 230000003111 delayed effect Effects 0.000 description 1
- 230000001419 dependent effect Effects 0.000 description 1
- 238000009792 diffusion process Methods 0.000 description 1
- 239000003814 drug Substances 0.000 description 1
- 229940079593 drug Drugs 0.000 description 1
- 239000000428 dust Substances 0.000 description 1
- 230000005684 electric field Effects 0.000 description 1
- 230000008030 elimination Effects 0.000 description 1
- 238000003379 elimination reaction Methods 0.000 description 1
- 210000003743 erythrocyte Anatomy 0.000 description 1
- 239000003925 fat Substances 0.000 description 1
- 230000002349 favourable effect Effects 0.000 description 1
- 210000003608 fece Anatomy 0.000 description 1
- 239000012530 fluid Substances 0.000 description 1
- 239000000446 fuel Substances 0.000 description 1
- 230000005484 gravity Effects 0.000 description 1
- 229910052736 halogen Inorganic materials 0.000 description 1
- 230000003862 health status Effects 0.000 description 1
- 238000010438 heat treatment Methods 0.000 description 1
- 238000000265 homogenisation Methods 0.000 description 1
- 230000005965 immune activity Effects 0.000 description 1
- 230000001939 inductive effect Effects 0.000 description 1
- 208000015181 infectious disease Diseases 0.000 description 1
- 230000004054 inflammatory process Effects 0.000 description 1
- 150000002576 ketones Chemical class 0.000 description 1
- 150000002632 lipids Chemical class 0.000 description 1
- 230000007774 longterm Effects 0.000 description 1
- 229920002521 macromolecule Polymers 0.000 description 1
- 230000014759 maintenance of location Effects 0.000 description 1
- 239000012528 membrane Substances 0.000 description 1
- 239000000693 micelle Substances 0.000 description 1
- 235000015097 nutrients Nutrition 0.000 description 1
- 229920002114 octoxynol-9 Polymers 0.000 description 1
- CELWCAITJAEQNL-UHFFFAOYSA-N oxan-2-ol Chemical compound OC1CCCCO1 CELWCAITJAEQNL-UHFFFAOYSA-N 0.000 description 1
- 238000005192 partition Methods 0.000 description 1
- 244000052769 pathogen Species 0.000 description 1
- 230000002572 peristaltic effect Effects 0.000 description 1
- 238000006116 polymerization reaction Methods 0.000 description 1
- 244000144977 poultry Species 0.000 description 1
- 238000007639 printing Methods 0.000 description 1
- 102000004196 processed proteins & peptides Human genes 0.000 description 1
- 108090000765 processed proteins & peptides Proteins 0.000 description 1
- 238000000746 purification Methods 0.000 description 1
- 238000011002 quantification Methods 0.000 description 1
- 238000011158 quantitative evaluation Methods 0.000 description 1
- 235000020185 raw untreated milk Nutrition 0.000 description 1
- 238000011867 re-evaluation Methods 0.000 description 1
- 230000001172 regenerating effect Effects 0.000 description 1
- 238000012552 review Methods 0.000 description 1
- MYFATKRONKHHQL-UHFFFAOYSA-N rhodamine 123 Chemical compound [Cl-].COC(=O)C1=CC=CC=C1C1=C2C=CC(=[NH2+])C=C2OC2=CC(N)=CC=C21 MYFATKRONKHHQL-UHFFFAOYSA-N 0.000 description 1
- 210000003296 saliva Anatomy 0.000 description 1
- 238000007789 sealing Methods 0.000 description 1
- 230000001568 sexual effect Effects 0.000 description 1
- 239000011343 solid material Substances 0.000 description 1
- 238000000527 sonication Methods 0.000 description 1
- 241000894007 species Species 0.000 description 1
- 210000002784 stomach Anatomy 0.000 description 1
- 239000000758 substrate Substances 0.000 description 1
- 210000004243 sweat Anatomy 0.000 description 1
- 238000012549 training Methods 0.000 description 1
- 238000002604 ultrasonography Methods 0.000 description 1
- 208000000143 urethritis Diseases 0.000 description 1
- 208000019206 urinary tract infection Diseases 0.000 description 1
- 230000035899 viability Effects 0.000 description 1
- 238000005406 washing Methods 0.000 description 1
- 239000002699 waste material Substances 0.000 description 1
- 239000002351 wastewater Substances 0.000 description 1
- 238000003466 welding Methods 0.000 description 1
Classifications
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N15/00—Investigating characteristics of particles; Investigating permeability, pore-volume or surface-area of porous materials
- G01N15/10—Investigating individual particles
- G01N15/14—Optical investigation techniques, e.g. flow cytometry
- G01N15/1468—Optical investigation techniques, e.g. flow cytometry with spatial resolution of the texture or inner structure of the particle
- G01N15/147—Optical investigation techniques, e.g. flow cytometry with spatial resolution of the texture or inner structure of the particle the analysis being performed on a sample stream
-
- B—PERFORMING OPERATIONS; TRANSPORTING
- B01—PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
- B01L—CHEMICAL OR PHYSICAL LABORATORY APPARATUS FOR GENERAL USE
- B01L3/00—Containers or dishes for laboratory use, e.g. laboratory glassware; Droppers
- B01L3/50—Containers for the purpose of retaining a material to be analysed, e.g. test tubes
- B01L3/502—Containers for the purpose of retaining a material to be analysed, e.g. test tubes with fluid transport, e.g. in multi-compartment structures
- B01L3/5027—Containers for the purpose of retaining a material to be analysed, e.g. test tubes with fluid transport, e.g. in multi-compartment structures by integrated microfluidic structures, i.e. dimensions of channels and chambers are such that surface tension forces are important, e.g. lab-on-a-chip
- B01L3/502715—Containers for the purpose of retaining a material to be analysed, e.g. test tubes with fluid transport, e.g. in multi-compartment structures by integrated microfluidic structures, i.e. dimensions of channels and chambers are such that surface tension forces are important, e.g. lab-on-a-chip characterised by interfacing components, e.g. fluidic, electrical, optical or mechanical interfaces
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N15/00—Investigating characteristics of particles; Investigating permeability, pore-volume or surface-area of porous materials
- G01N15/10—Investigating individual particles
- G01N15/14—Optical investigation techniques, e.g. flow cytometry
- G01N15/1429—Signal processing
- G01N15/1433—Signal processing using image recognition
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N15/00—Investigating characteristics of particles; Investigating permeability, pore-volume or surface-area of porous materials
- G01N15/10—Investigating individual particles
- G01N15/14—Optical investigation techniques, e.g. flow cytometry
- G01N15/1434—Optical arrangements
-
- B—PERFORMING OPERATIONS; TRANSPORTING
- B01—PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
- B01L—CHEMICAL OR PHYSICAL LABORATORY APPARATUS FOR GENERAL USE
- B01L2300/00—Additional constructional details
- B01L2300/02—Identification, exchange or storage of information
- B01L2300/021—Identification, e.g. bar codes
-
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
- Y10T—TECHNICAL SUBJECTS COVERED BY FORMER US CLASSIFICATION
- Y10T436/00—Chemistry: analytical and immunological testing
- Y10T436/11—Automated chemical analysis
- Y10T436/117497—Automated chemical analysis with a continuously flowing sample or carrier stream
-
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
- Y10T—TECHNICAL SUBJECTS COVERED BY FORMER US CLASSIFICATION
- Y10T436/00—Chemistry: analytical and immunological testing
- Y10T436/25—Chemistry: analytical and immunological testing including sample preparation
- Y10T436/25375—Liberation or purification of sample or separation of material from a sample [e.g., filtering, centrifuging, etc.]
Landscapes
- Chemical & Material Sciences (AREA)
- Health & Medical Sciences (AREA)
- Dispersion Chemistry (AREA)
- Analytical Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- Immunology (AREA)
- Pathology (AREA)
- Physics & Mathematics (AREA)
- Life Sciences & Earth Sciences (AREA)
- Biochemistry (AREA)
- General Physics & Mathematics (AREA)
- Engineering & Computer Science (AREA)
- Signal Processing (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Clinical Laboratory Science (AREA)
- Hematology (AREA)
- Investigating Or Analysing Materials By Optical Means (AREA)
- Investigating Or Analysing Biological Materials (AREA)
- Investigating, Analyzing Materials By Fluorescence Or Luminescence (AREA)
- Sampling And Sample Adjustment (AREA)
- Computer Vision & Pattern Recognition (AREA)
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| DKPA199801433 | 1998-11-05 | ||
| DKPA199801469 | 1998-11-11 | ||
| PCT/DK1999/000605 WO2000028297A2 (en) | 1998-11-05 | 1999-11-05 | A method for the assessment of particles and a system and a device for use in the method |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| TW468040B true TW468040B (en) | 2001-12-11 |
Family
ID=26065742
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| TW088120318A TW468040B (en) | 1998-11-05 | 1999-11-20 | A method for the assessment of particles and a system and a device for use in the method |
Country Status (9)
| Country | Link |
|---|---|
| US (1) | US8906697B2 (https=) |
| EP (1) | EP1125105A2 (https=) |
| JP (1) | JP2002529729A (https=) |
| AU (1) | AU766434B2 (https=) |
| CA (1) | CA2349548C (https=) |
| HK (1) | HK1039805A1 (https=) |
| NZ (1) | NZ511560A (https=) |
| TW (1) | TW468040B (https=) |
| WO (1) | WO2000028297A2 (https=) |
Cited By (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| TWI708057B (zh) * | 2019-06-05 | 2020-10-21 | 王錦弘 | 離心式反應微管、離心式反應裝置及其離心式檢驗方法 |
| US12390806B2 (en) | 2019-06-13 | 2025-08-19 | Chin Hung Wang | Centrifugal reaction microtube, centrifugal reaction device and its centrifugal examination method |
Families Citing this family (43)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JP2003530568A (ja) | 2000-04-11 | 2003-10-14 | シェモメテック・アクティーゼルスカブ | 試料の蛍光を検出するための方法および装置 |
| JP2004505245A (ja) * | 2000-07-26 | 2004-02-19 | シェモメテック・アクティーゼルスカブ | 空間解像型酵素結合アッセイ |
| WO2003025563A1 (en) * | 2001-09-16 | 2003-03-27 | Chemometec A/S | Method and a system for detecting and optionally isolating a rare event particle |
| US11243494B2 (en) | 2002-07-31 | 2022-02-08 | Abs Global, Inc. | Multiple laminar flow-based particle and cellular separation with laser steering |
| WO2004040314A1 (en) * | 2002-10-31 | 2004-05-13 | Chemometec A/S | A method for assessment of particles |
| JP4606727B2 (ja) * | 2003-11-28 | 2011-01-05 | 株式会社アドバンス | 体液成分診断用チップ |
| US7333197B2 (en) * | 2004-11-17 | 2008-02-19 | Honeywell International Inc. | Raman detection based flow cytometer |
| US7738094B2 (en) | 2007-01-26 | 2010-06-15 | Becton, Dickinson And Company | Method, system, and compositions for cell counting and analysis |
| JP4509167B2 (ja) * | 2007-11-05 | 2010-07-21 | ソニー株式会社 | 流路構造、これを備えた流路基板及び流体制御方法 |
| EP2312943B1 (en) | 2008-07-14 | 2019-11-06 | Chemometec A/S | Method for assessing viable cells and the use of n-(7-dimethylamino-4-methyl-3-coumarinyl)-maleimide (dacm) or n-(9-acridinyl)maleimide (nam) for assessment of apoptosis. |
| WO2010006616A2 (en) | 2008-07-14 | 2010-01-21 | Chemometec A/S | Method and kit for examination of cells using n-(9-acridinyl)maleimide (nam) or using 7-diethylamino-3-((4'-(iodoacetyl)amino)phenyl)-4-methylcoumarin (cpi) |
| US8860938B2 (en) | 2008-10-21 | 2014-10-14 | Chemometec A/S | Apparatus and methods for analysing fluorescent particles |
| US9821318B2 (en) * | 2010-09-26 | 2017-11-21 | Da Yu Enterprises, L.L.C. | Separation of analytes |
| US10908066B2 (en) | 2010-11-16 | 2021-02-02 | 1087 Systems, Inc. | Use of vibrational spectroscopy for microfluidic liquid measurement |
| US20120225475A1 (en) | 2010-11-16 | 2012-09-06 | 1087 Systems, Inc. | Cytometry system with quantum cascade laser source, acoustic detector, and micro-fluidic cell handling system configured for inspection of individual cells |
| US8941062B2 (en) | 2010-11-16 | 2015-01-27 | 1087 Systems, Inc. | System for identifying and sorting living cells |
| CN103917870B (zh) | 2011-11-16 | 2016-04-13 | 贝克顿·迪金森公司 | 用于检测样品中的分析物的方法和系统 |
| BR112015010695B1 (pt) | 2013-01-11 | 2023-03-07 | Becton, Dickinson And Company | Dispositivo microfluídico e método para realizar um ensaio de uma amostra líquida, método para formar um dispositivo microfluídico, sistema e kit |
| WO2014191003A1 (en) | 2013-05-28 | 2014-12-04 | Chemometec A/S | Image forming cytometer |
| US8961904B2 (en) | 2013-07-16 | 2015-02-24 | Premium Genetics (Uk) Ltd. | Microfluidic chip |
| US11796449B2 (en) | 2013-10-30 | 2023-10-24 | Abs Global, Inc. | Microfluidic system and method with focused energy apparatus |
| CN113477149B (zh) | 2013-11-06 | 2023-09-12 | 贝克顿·迪金森公司 | 微流体性装置和制造和使用其的方法 |
| US10018640B2 (en) | 2013-11-13 | 2018-07-10 | Becton, Dickinson And Company | Optical imaging system and methods for using the same |
| EP3692914B1 (en) | 2014-10-14 | 2023-12-27 | Becton, Dickinson and Company | Blood sample management using open cell foam |
| JP2017506340A (ja) | 2014-10-14 | 2017-03-02 | ベクトン・ディキンソン・アンド・カンパニーＢｅｃｔｏｎ， Ｄｉｃｋｉｎｓｏｎ Ａｎｄ Ｃｏｍｐａｎｙ | オープンセル発泡体を用いた血液サンプルの管理 |
| EP3259579B1 (en) | 2015-02-19 | 2022-09-14 | 1087 Systems, Inc. | Scanning infrared measurement system |
| EP3154697B1 (en) | 2015-03-10 | 2018-06-20 | Becton, Dickinson and Company | Biological fluid micro-sample management device |
| WO2017040650A1 (en) | 2015-09-01 | 2017-03-09 | Becton, Dickinson And Company | Depth filtration device for separating specimen phases |
| FR3051045B1 (fr) | 2016-05-04 | 2020-11-20 | Ipratech Sa | Dispositif de confinement a chambre de mesure de taille variable delimitee en partie par une membrane flexible |
| EP3796998A1 (en) | 2018-05-23 | 2021-03-31 | ABS Global, Inc. | Systems and methods for particle focusing in microchannels |
| WO2020128561A1 (en) | 2018-12-21 | 2020-06-25 | Premium Genetics (Uk) Ltd. | System and methods for sub-population identification |
| EP3955735B1 (en) | 2019-04-18 | 2024-05-22 | ABS Global, Inc. | System and process for continuous addition of cryoprotectant |
| US20220193668A1 (en) * | 2019-04-18 | 2022-06-23 | Siemens Healthcare Diagnostics Inc. | Integrated microfluidic device with pipette adaptation |
| US11628439B2 (en) | 2020-01-13 | 2023-04-18 | Abs Global, Inc. | Single-sheath microfluidic chip |
| EP4232601A4 (en) | 2020-10-21 | 2024-10-09 | ABS Global, Inc. | METHODS AND SYSTEMS FOR PROCESSING GENETIC SAMPLES TO DETERMINE IDENTITY OR DETECT CONTAMINATION |
| JP7633402B2 (ja) | 2020-11-23 | 2025-02-19 | エイビーエス グローバル、インコーポレイテッド | モジュール式フロー・サイトメトリ・システム及びサンプル処理方法 |
| CN112945637A (zh) * | 2021-01-28 | 2021-06-11 | 上海浚真生命科学有限公司 | 取样装置 |
| KR102709769B1 (ko) * | 2021-04-28 | 2024-09-26 | 한국전자통신연구원 | 바이오 물질 제거 장치 |
| CN113444624A (zh) * | 2021-06-21 | 2021-09-28 | 清华大学深圳国际研究生院 | 一种依靠拉伸力驱动的核酸检测芯片及核酸检测设备 |
| USD1118965S1 (en) | 2021-11-12 | 2026-03-17 | Abs Global, Inc. | Flow cytometry device |
| CN114166719B (zh) * | 2021-11-27 | 2022-08-12 | 北京擎科生物科技有限公司 | 核酸合成载体筛选方法与装置 |
| CN115555067A (zh) * | 2022-09-28 | 2023-01-03 | 深圳市卓润生物科技有限公司 | 离心连续反应结构及实现方法与离心式生物样本检测装置 |
| US12412309B2 (en) * | 2022-10-17 | 2025-09-09 | Saudi Arabian Oil Company | Chemical purity assessment by image analysis |
Family Cites Families (39)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| SE399768B (sv) | 1975-09-29 | 1978-02-27 | Lilja Jan E | Kyvett for provtagning, blandning av, provet med ett reagensmedel och direkt utforande av, serskilt optisk, analys av det med reagensmedlet blandade provet |
| DE2904909C3 (de) * | 1979-02-09 | 1981-11-12 | Fa. Carl Zeiss, 7920 Heidenheim | Küvette für optische Messungen |
| US4338024A (en) * | 1980-05-02 | 1982-07-06 | International Remote Imaging Systems, Inc. | Flow analyzer and system for analysis of fluids with particles |
| DE3246592C1 (de) | 1982-12-16 | 1983-10-27 | Eppendorf Gerätebau Netheler + Hinz GmbH, 2000 Hamburg | Kuevette zur Mischung und fuer optische Untersuchungen |
| US5221605A (en) * | 1984-10-31 | 1993-06-22 | Igen, Inc. | Luminescent metal chelate labels and means for detection |
| US5164598A (en) | 1985-08-05 | 1992-11-17 | Biotrack | Capillary flow device |
| US4756884A (en) * | 1985-08-05 | 1988-07-12 | Biotrack, Inc. | Capillary flow device |
| US5128104A (en) * | 1987-04-27 | 1992-07-07 | Murphy Harold R | Cuvette for automated testing machine |
| JP2935529B2 (ja) * | 1990-03-01 | 1999-08-16 | シスメックス株式会社 | 白血球分類方法および試薬 |
| US4874691A (en) * | 1987-10-16 | 1989-10-17 | Quadra Logic Technologies Inc. | Membrane-supported immunoassays |
| US5208147A (en) * | 1988-07-21 | 1993-05-04 | Radiometer A/S | Means for measuring a characteristic in a sample fluid |
| US5104813A (en) | 1989-04-13 | 1992-04-14 | Biotrack, Inc. | Dilution and mixing cartridge |
| IE76732B1 (en) * | 1990-08-07 | 1997-11-05 | Becton Dickinson Co | One step test for absolute counts |
| US5371020A (en) | 1991-09-19 | 1994-12-06 | Radiometer A/S | Method of photometric in vitro determination of the content of an analyte in a sample |
| US5726026A (en) * | 1992-05-01 | 1998-03-10 | Trustees Of The University Of Pennsylvania | Mesoscale sample preparation device and systems for determination and processing of analytes |
| JP3145487B2 (ja) | 1992-06-12 | 2001-03-12 | シスメックス株式会社 | 粒子分析装置 |
| JP3215175B2 (ja) * | 1992-08-10 | 2001-10-02 | シスメックス株式会社 | 粒子分析装置 |
| JP2763468B2 (ja) | 1992-12-25 | 1998-06-11 | 株式会社日立製作所 | 光散乱を用いた液体内の粒子分類装置 |
| US5439578A (en) | 1993-06-03 | 1995-08-08 | The Governors Of The University Of Alberta | Multiple capillary biochemical analyzer |
| US5571479A (en) | 1994-02-18 | 1996-11-05 | Hoffmann-La Roche Inc. | Cuvette |
| JPH07294414A (ja) | 1994-04-25 | 1995-11-10 | Hitachi Ltd | 粒子画像解析方法及び装置 |
| US5656499A (en) | 1994-08-01 | 1997-08-12 | Abbott Laboratories | Method for performing automated hematology and cytometry analysis |
| CA2156226C (en) * | 1994-08-25 | 1999-02-23 | Takayuki Taguchi | Biological fluid analyzing device and method |
| US5627041A (en) * | 1994-09-02 | 1997-05-06 | Biometric Imaging, Inc. | Disposable cartridge for an assay of a biological sample |
| US5585069A (en) * | 1994-11-10 | 1996-12-17 | David Sarnoff Research Center, Inc. | Partitioned microelectronic and fluidic device array for clinical diagnostics and chemical synthesis |
| CA2181190C (en) * | 1994-11-14 | 2001-02-06 | Peter Wilding | Mesoscale sample preparation device and systems for determination and processing of analytes |
| SE504193C2 (sv) | 1995-04-21 | 1996-12-02 | Hemocue Ab | Kapillär mikrokyvett |
| US6143247A (en) * | 1996-12-20 | 2000-11-07 | Gamera Bioscience Inc. | Affinity binding-based system for detecting particulates in a fluid |
| WO1997007390A1 (en) * | 1995-08-21 | 1997-02-27 | Foss Electric A/S | A method and an apparatus for determining the number of particles or cells in a liquid sample |
| US20010055812A1 (en) * | 1995-12-05 | 2001-12-27 | Alec Mian | Devices and method for using centripetal acceleration to drive fluid movement in a microfluidics system with on-board informatics |
| US5748311A (en) * | 1996-03-11 | 1998-05-05 | Hamann; Oliver | Apparatus and method of particle geometry measurement by speckle pattern analysis |
| US5962215A (en) | 1996-04-05 | 1999-10-05 | Mercury Diagnostics, Inc. | Methods for testing the concentration of an analyte in a body fluid |
| US5863801A (en) * | 1996-06-14 | 1999-01-26 | Sarnoff Corporation | Automated nucleic acid isolation |
| US6429025B1 (en) * | 1996-06-28 | 2002-08-06 | Caliper Technologies Corp. | High-throughput screening assay systems in microscale fluidic devices |
| US5800784A (en) | 1996-07-09 | 1998-09-01 | Horn; Marcus J. | Chemical sample treatment system and cassette, and methods for effecting multistep treatment process |
| US5935864A (en) | 1996-10-07 | 1999-08-10 | Saliva Diagnostic Systems Inc. | Method and kit for collecting samples of liquid specimens for analytical testing |
| AU739824B2 (en) * | 1997-05-05 | 2001-10-18 | Chemometec A/S | A method and a system for determination of particles in a liquid sample |
| JPH11295208A (ja) | 1998-04-13 | 1999-10-29 | Sysmex Corp | 粒子撮像装置 |
| CA2341896A1 (en) * | 1998-08-28 | 2000-03-09 | Febit Ferrarius Biotechnology Gmbh | Support for a method for determining an analyte and a method for producing the support |
-
1999
- 1999-11-05 NZ NZ511560A patent/NZ511560A/xx not_active IP Right Cessation
- 1999-11-05 WO PCT/DK1999/000605 patent/WO2000028297A2/en not_active Ceased
- 1999-11-05 EP EP99953733A patent/EP1125105A2/en not_active Withdrawn
- 1999-11-05 CA CA2349548A patent/CA2349548C/en not_active Expired - Lifetime
- 1999-11-05 HK HK02100908.9A patent/HK1039805A1/zh unknown
- 1999-11-05 AU AU10320/00A patent/AU766434B2/en not_active Expired
- 1999-11-05 JP JP2000581430A patent/JP2002529729A/ja active Pending
- 1999-11-20 TW TW088120318A patent/TW468040B/zh not_active IP Right Cessation
-
2005
- 2005-06-23 US US11/296,662 patent/US8906697B2/en not_active Expired - Lifetime
Cited By (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| TWI708057B (zh) * | 2019-06-05 | 2020-10-21 | 王錦弘 | 離心式反應微管、離心式反應裝置及其離心式檢驗方法 |
| US12390806B2 (en) | 2019-06-13 | 2025-08-19 | Chin Hung Wang | Centrifugal reaction microtube, centrifugal reaction device and its centrifugal examination method |
Also Published As
| Publication number | Publication date |
|---|---|
| NZ511560A (en) | 2002-11-26 |
| US20070207551A1 (en) | 2007-09-06 |
| WO2000028297A3 (en) | 2000-10-05 |
| CA2349548A1 (en) | 2000-05-18 |
| WO2000028297A2 (en) | 2000-05-18 |
| CA2349548C (en) | 2012-09-25 |
| HK1039805A1 (zh) | 2002-05-10 |
| AU1032000A (en) | 2000-05-29 |
| EP1125105A2 (en) | 2001-08-22 |
| US8906697B2 (en) | 2014-12-09 |
| JP2002529729A (ja) | 2002-09-10 |
| AU766434B2 (en) | 2003-10-16 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| TW468040B (en) | A method for the assessment of particles and a system and a device for use in the method | |
| US7192777B2 (en) | Apparatus and method for process monitoring | |
| TWI486570B (zh) | 使用濁度光散射技術以確保樣品妥適性之技術 | |
| JP6453310B2 (ja) | 細胞運動性の分析のための装置 | |
| CN105424665B (zh) | 用于快速确定医学疾病的设备、系统和方法 | |
| NZ500686A (en) | A method and a system for determination of the number of somatic cells in milk, utilizing electromagnetic radiation | |
| CN101688840A (zh) | 光学测量仪器 | |
| JP2016522880A (ja) | 体液内の粒子及び可溶化学物質の体外での検出のためのシステムおよび方法 | |
| JP5606285B2 (ja) | 分析方法および装置 | |
| JP4842796B2 (ja) | 微生物検査装置及び微生物検査用計測チップ | |
| JP5543310B2 (ja) | イムノクロマトグラフ検査方法および装置 | |
| JP5543888B2 (ja) | イムノクロマトグラフ検査方法および装置 | |
| JPH02170053A (ja) | 微生物の検出方法及び装置 | |
| JP2021073454A (ja) | センサデバイス | |
| US20180322247A1 (en) | Systems, Methods and Computer Readable Storage Media for Analyzing a Sample | |
| EP2623981B1 (en) | Testing method and device | |
| US20040211915A1 (en) | Method for the determination of substances in a liquid or gaseous sample | |
| EP1181553A1 (en) | Method and device for counting cells in urine | |
| CN112041677A (zh) | 粪便样本检查装置、粪便样本检查方法 |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| GD4A | Issue of patent certificate for granted invention patent | ||
| MK4A | Expiration of patent term of an invention patent |